Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Jan 28, 2021 8:33pm
143 Views
Post# 32416584

RE:RE:Repeated mistakes are not "mistakes"

RE:RE:Repeated mistakes are not "mistakes"Here we go with one of my stories, back in the day I was invested both in Nokia and Ericsson both at the time mostly in the business of making cellphones and both initially had similar market share in the industry.
Both companies had a major manufacturing problem in one of their sites, the CEO of Nokia flew on the same day and managed to rectify the issue within 24 hours but the CEO of the Ericsson decided to deal with the issue remotely as a result the site experienced major setback for a couple weeks. Nokia in the next couple years became one of the biggest cell phone maker in the world while Ericsson eventually gave up the hardware side of business and moved on to the software side with less demand and revenues at that time.
Point is being proactive is a must for successful companies, the company surely knew the market reaction to the deal will be negative so they should line up few strategic measures as a damage control and having your IP down for more than a week is not one of them.
<< Previous
Bullboard Posts
Next >>